Spect Inc.

Spect Inc. is a data science company revolutionizing eyecare with its end-to-end eye disease screening solutions. Founded in 2017 and headquartered in the United States, Spect's mission is to prevent blindness through early detection of eye disease and build a platform for healthcare data analytics. The company's innovative approach leverages the eye as the Check Engine Light of the Body™, providing pivotal insights into both eye-specific conditions like diabetic retinopathy, glaucoma, and age-related macular degeneration, as well as indications of whole-body diseases such as stroke and Parkinson's. Spect's human-in-the-loop telemedicine platform trains medical assistants to deliver diagnostic reports in minutes, bridging critical healthcare gaps for patients and clinics. In its latest funding round on 30 November 2021, Spect secured a $3.50M Seed Round investment from notable investors including AME Cloud Ventures, Morado Ventures, 10x Group, and XTX Ventures. As a leader in the Health Care industry, Spect's pioneering efforts in eyecare technology and healthcare data analytics make it a promising venture for investors seeking to support innovative solutions with the potential for profound impact on global health.